toxicity studies Hematology and Clinical Chemistry

CBI offers a wide variety of toxicology and pharmacokinetic studies to support both early discovery and development phase compounds.

Toxicology Capabilities

Acute, subacute, and chronic toxicity studies
Oral, ocular, dermal, intra-tracheal, IV, IM, SC, IP, joint fluid, short-infusion and other routes of administration including intracranial by stereotaxic injection or infusion
Hematology and Clinical Chemistry
Clinical pathology research services are available in either a research or GLP environment on a wide variety of laboratory animal species.
Small molecules, proteins, antibodies, viral vectors
Rapid turn-around time
GLP and Non-GLP
Data collection and assessment using validated LABCAT Data Aquisition Program

Special Toxicology Capabilities for Unusual or Investigational Toxicology Issues

Quick, inexpensive “mini-tox” studies (compound sparing for rapid assessment of new molecules in rodents)
Ocular, dermal, short infusion, intracerebral, intrathecal, and other routes
Surgical toxicity studies
Hypothesis-directed or investigative studies
Small molecules, proteins, antibodies
Radionuclide studies

Quick “mini-PK” studies (compound sparing for rapid assessment of new molecules in rodents)
Routine single or multiple dose pharmacokinetic studies
Oral, ocular, dermal, intra-tracheal, IV, IM, SC, IP, short-infusion and other routes
Small molecules, proteins, antibodies
Radionuclide studies
More information on pharmacokinetic capabilities